Key result
Right anterolateral thoracotomy is linked to ~1 day shorter hospital stay versus median sternotomy.
Why the study?
The advantages of the right anterolateral thoracotomy approach over standard median sternotomy for mitral valve surgery remained debatable.
Does right anterolateral thoracotomy improve postoperative clinical outcomes compared to median sternotomy in patients undergoing mitral valve replacement?
Observational (n=40)
Does right anterolateral thoracotomy improve postoperative clinical outcomes compared to median sternotomy in patients undergoing mitral valve replacement?
Absolute Event Rate: 7.2% vs 8.4%
p-value: p=0.01
Right anterolateral thoracotomy for mitral valve replacement is associated with reduced blood loss, shorter ICU and hospital stays, and higher patient satisfaction compared to median sternotomy, despite longer operative times.
Background: The advantages of the right anterolateral thoracotomy (RALT) approach for mitral valve surgery over standard median sternotomy (MS) are still debatable. The objective of this study was to evaluate and compare the postoperative clinical outcome after RALT and MS for mitral valve replacement. Methods: This prospective observational study included 40 patients who underwent mitral valve replacement between January 2016 and August 2018. Patients were assigned to two groups, the first group included 20 patients who had conventional median sternotomy approach and the second group included 20 patients who had right anterolateral thoracotomy with the complete cannulation and aortic cross-clamping conducted through the same incision. Results: In comparison to MS, RALT had significantly higher cross-clamp time (77.7±16.1 vs 45.8±8.7 minutes, P < 0.01), total bypass time (105.2±12.7 vs 72.2±10.4 minutes, P < 0.01), and total operative time (287±41 vs 231±36 min, P < 0.01), in addition to significantly lower ventilation time (4.2±1.51 vs 6.1±1.84 hours, P < 0.01), blood loss (229±85 vs 335±137 ml), amount of blood transfusion (1.41±0.6 vs 2.19±1.1 units, P < 0.01), ICU stay duration (2.11±0.49 vs 2.78±0.82 days, P < 0.01), pain scores at 1st and 2nd postoperative days (5.67±0.79 vs 7.81±0.53, p < 0.01), and total hospital stay duration (7.2±1.3 vs 8.4±1.6 days, P = 0.01). Patients' satisfaction about their wound was significantly higher in RALT group compared to MS group (95% vs 30%, P < 0.01). Conclusion: The RALT approach for mitral valve surgery could be a safe and effective approach when compared to median sternotomy. RALT could be associated with a reduction of blood loss, blood transfusion, wound infection, in addition to shorter ICU and hospital stay.
No takes yet. Share an insight, caveat, or question.
Attallah et al. (2020) conducted an observational in Mitral valve replacement (n=40). Right anterolateral thoracotomy (RALT) vs. Conventional median sternotomy (MS) was evaluated on Total hospital stay duration (days) (p=0.01). Right anterolateral thoracotomy for mitral valve replacement was associated with shorter hospital stay (7.2 vs 8.4 days, P=0.01), shorter ICU stay, and less blood loss than median sternotomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: